Clinical Trial Update: Long-Term Safety and Tolerability Study of NKTR-181 in Subjects With Chronic Low Back Pain or Chronic Non-Cancer Pain [Phase 3]

View source ↗

Summary

A Phase 3 long-term safety and tolerability study of NKTR-181 in chronic low back pain and chronic non-cancer pain has completed, with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Low Back Pain
• Pain

Drugs mentioned

• NKTR-181

Snippet

Sponsor: Nektar Therapeutics | Conditions: Low Back Pain, Chronic Pain | Phase 3 | Status: COMPLETED | Results posted: 2020-10-08